RenovoRx Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . RenovoRx
RNXT Stock  USD 1.29  0.08  6.61%   
RenovoRx financial statements provide useful quarterly and yearly information to potential RenovoRx investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on RenovoRx financial statements helps investors assess RenovoRx's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting RenovoRx's valuation are summarized below:
Market Capitalization
31 M
Earnings Share
(0.58)
There are currently ninety-eight trending fundamental ratios for RenovoRx that can be evaluated and compared over time across competitors. All traders should check out RenovoRx's recent fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 47 M in 2024. Enterprise Value is likely to gain to about 44.5 M in 2024
Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 116.5 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.
  
Check out the analysis of RenovoRx Correlation against competitors.
For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

RenovoRx Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 M1.5 M3.4 M
Slightly volatile
Short and Long Term Debt Total2.4 M2.5 M9.1 M
Slightly volatile
Other Current Liabilities666.4 K614 K406.6 K
Slightly volatile
Total Current Liabilities1.3 M1.2 M1.1 M
Slightly volatile
Accounts Payable510.4 K561 K511.5 K
Pretty Stable
Cash1.1 M1.2 M3.1 M
Pretty Stable
Non Currrent Assets Other122 K116.1 K25.9 K
Slightly volatile
Cash And Short Term Investments1.1 M1.2 M3.1 M
Pretty Stable
Common Stock Total Equity800900980
Slightly volatile
Common Stock Shares Outstanding10 M10.3 M8.9 M
Slightly volatile
Liabilities And Stockholders Equity1.4 M1.5 M3.4 M
Slightly volatile
Non Current Liabilities Total4.7 M3.3 M9.7 M
Slightly volatile
Other Current Assets542.1 K293 K285.6 K
Slightly volatile
Other Stockholder Equity24.8 M38.4 M9.3 M
Slightly volatile
Total Liabilities5.8 M4.5 M10.7 M
Slightly volatile
Total Current Assets1.4 M1.5 M3.4 M
Slightly volatile
Capital Stock800900980
Slightly volatile
Common Stock800900980
Slightly volatile
Current Deferred Revenue248.8 K279.9 K304.8 K
Slightly volatile
Long Term Debt18.4 K20.7 K22.5 K
Slightly volatile
Short and Long Term Debt2.2 M2.5 M2.7 M
Slightly volatile
Short Term Debt2.2 M2.5 M2.7 M
Slightly volatile
Property Plant Equipment4.8 K5.4 K5.9 K
Slightly volatile

RenovoRx Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income64.3 K111 K61.5 K
Very volatile
Depreciation And Amortization5.1 K5.4 K258.6 K
Pretty Stable
Selling General Administrative3.5 M5.7 M1.8 M
Slightly volatile
Other Operating Expenses7.5 M11.4 M5.1 M
Slightly volatile
Research Development4 M5.7 M3.3 M
Slightly volatile
Total Operating Expenses7.5 M11.4 M5.1 M
Slightly volatile
Cost Of Revenue6 K5.4 K8.4 K
Slightly volatile
Selling And Marketing Expenses4.6 M5.2 M5.6 M
Slightly volatile

RenovoRx Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings2.2 M1.8 M2.9 M
Slightly volatile
Stock Based Compensation1.1 M1.1 M228.7 K
Slightly volatile
Begin Period Cash Flow6.4 M4.4 M5.6 M
Pretty Stable
Total Cash From Financing Activities6.8 M5 M4.4 M
Slightly volatile
End Period Cash Flow1.1 M1.2 M3 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation1.341.51.6338
Slightly volatile
Payables Turnover0.01560.01290.0164
Slightly volatile
Cash Per Share0.110.1140.3666
Slightly volatile
Days Payables Outstanding21.5 K29.2 K22.6 K
Slightly volatile
Income Quality0.741.00250.8816
Very volatile
Net Debt To EBITDA0.09780.1032.2031
Slightly volatile
Current Ratio1.191.24773.6668
Pretty Stable
Graham Number4.412.55383.7424
Slightly volatile
Capex Per Share0.00130.00150.0016
Slightly volatile
Interest Debt Per Share0.010.01050.2942
Slightly volatile
Debt To Assets1.171.311.4287
Slightly volatile
Days Of Payables Outstanding21.5 K29.2 K22.6 K
Slightly volatile
Ebt Per Ebit1.140.89791.0124
Slightly volatile
Quick Ratio1.191.24773.6668
Pretty Stable
Net Income Per E B T1.171.141.0274
Slightly volatile
Cash Ratio0.950.99833.3709
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.80.90.9822
Slightly volatile
Debt Ratio1.171.311.4287
Slightly volatile

RenovoRx Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap47 M23.6 M55.1 M
Slightly volatile
Enterprise Value44.5 M22.4 M60.4 M
Slightly volatile

RenovoRx Fundamental Market Drivers

Cash And Short Term Investments1.2 M

RenovoRx Upcoming Events

7th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About RenovoRx Financial Statements

RenovoRx shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although RenovoRx investors may analyze each financial statement separately, they are all interrelated. The changes in RenovoRx's assets and liabilities, for example, are also reflected in the revenues and expenses on on RenovoRx's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue279.9 K248.8 K
Cost Of Revenue5.4 K6 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY